Absa Group posts audited FY2025 results – here’s what’s actually in the RNS
Absa Group Limited has announced that its audited financial results for the year ended 31 December 2025 are now published. This is a formal notice to say the full set of numbers is available to read, rather than a summary of performance.
The documents are accessible on the London Stock Exchange’s National Storage Mechanism (NSM) and via Absa’s own website. If you want the source material, use the links below:
Worth noting: the RNS doesn’t include headline figures, ratios or guidance – it simply confirms publication. Absa is incorporated in South Africa and lists securities in London (the notice references ISINs XS3225241457 and XS2339102878), so this update matters for both bondholders and any UK-based investors tracking the group.
What this means and why it matters
This is a routine but important housekeeping RNS. “Audited” means an external auditor has reviewed the numbers, which adds credibility compared with preliminary or unaudited updates. The NSM posting ensures UK market access to the official documents.
Without the figures in the text, I’d call the announcement neutral on its own. The signal is simply: the definitive FY2025 pack is out, go read it. The substance – profitability, capital strength, asset quality and any dividends – will be inside the PDFs, not here.
How to read Absa’s FY2025 as a bank investor
Banks are driven by a handful of levers. When you open the Results Booklet, these are the sections I’d go to first and why they move the dial:
- Net interest income and margin – shows how lending spreads held up against funding costs.
- Non-interest revenue – fees, trading and other income diversify earnings through the cycle.
- Cost-to-income ratio – a clean read on operating efficiency.
- Credit impairments and Stage 3 loans – the health of the loan book and coverage levels.
- Common Equity Tier 1 (CET1) ratio – core capital strength against risk-weighted assets.
- Liquidity (LCR/NSFR) and wholesale funding – resilience under stress and refinancing profile.
- Return on equity (ROE) – the bottom-line efficiency of capital employed.
- Dividend and payout policy – cash returns to shareholders, if declared; not disclosed in the RNS.
- Outlook and guidance – management’s read on credit demand, costs and risk trends into 2026.
- Segment and geography trends – which customer lines or regions are pulling their weight.
For bondholders, add covenant language (if any), leverage and capital stack developments, and the maturity ladder for outstanding notes. The two ISINs quoted in the RNS signal listed debt instruments that investors may want to cross-reference against the results and any accompanying presentation.
Positives and watch-outs from the announcement
- Positive: Audited financials are available, which is the definitive dataset for FY2025 analysis.
- Positive: Documents are posted to the NSM and the company website, aiding access and transparency.
- Neutral: No performance metrics, dividend details or guidance are included in the RNS itself – you must read the PDFs.
Key details at a glance
| Company | Absa Group Limited (South Africa-incorporated, reg no. 1986/003934/06) |
| Period covered | Full year ended 31 December 2025 |
| Results status | Audited; published |
| Publication date | 26 March 2026 |
| NSM document | View the NSM PDF |
| Results booklet | View the Absa Results Booklet |
| ISINs referenced | XS3225241457; XS2339102878 |
| Investor relations contact | Absa Group Limited, 7th Floor, Absa Towers West, 15 Troye Street, Johannesburg, 2001, South Africa |
What I’ll be checking in the PDFs
Given this is a bank, I’ll focus on whether earnings quality is improving or being flattered by one-offs. I’ll compare impairment charges with prior-year trends, look at Stage 2 migration, and see if non-performing loan coverage is conservative. On capital, I’ll check CET1 headroom relative to management’s target range and any regulatory minima disclosed.
I’ll also scan for dividend decisions (if any), buyback commentary, and whether management signals a change in risk appetite. On funding, I want to see term issuance completed in 2025, the 2026 maturity wall, and any shifts in deposit mix that might pressure margins. None of these specifics are in the RNS – they should be in the linked documents.
Bottom line
This is a straightforward “results are out” notice. The good news is the figures are audited and readily accessible. The less helpful bit is there are no numbers in the RNS itself.
If you hold Absa securities – equity or debt – your next step is to download the PDFs, zero in on capital, credit quality and cash returns, and then decide if the risk-reward stacks up for 2026. If anything material leaps out in the documents, expect follow-up commentary from the market in short order.